Dr Lee & Morris Pharma Private Limited
About Dr Lee & Morris Pharma Private Limited
Data last updated:
Dr Lee & Morris Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 17 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC304334. Its GSTIN is 27AAGCD5161L1ZE (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Kumar Sahu and Shradha Rani Sahu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.10 Vaibhav Nagar Borla W.T Patil Marg Chembur, Mumbai, Maharashtra, India – 400071.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net loss of ₹310 (net margin -0.3%) and EBITDA of -₹290 (EBITDA margin -0.3%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 49% over five years.
Company details
Contact details
Dr Lee & Morris Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressH.10 Vaibhav Nagar Borla W.T Patil Marg Chembur, Mumbai, Maharashtra, India – 400071
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Dr Lee & Morris Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr Lee & Morris Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dr Lee & Morris Pharma Private Limited, buy the company report.
Financials of Dr Lee & Morris Pharma Private Limited
FY 2025 filings availableDr Lee & Morris Pharma Private Limited reported revenue of ₹1.02 Lakh (down 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 49% over five years, including a 3% fall in the latest year. EBITDA rose 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹290 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹310 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.3% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr Lee & Morris Pharma Private Limited, buy the company report.
Board of directors of Dr Lee & Morris Pharma Private Limited
Dr Lee & Morris Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Sahu | Additional Director | 15 Mar 2018 | 8 Years 7 Months | Current |
| Shradha Rani Sahu | Additional Director | 27 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Dr Lee & Morris Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmexia Labs Private Limited | ₹1.02 Lakh (FY 2019) | -69.0% | Delhi, India | |||
| Kasturi Steel Alloys Private Limited | ₹1.02 Lakh (FY 2024) | 121.0% | Jalna, Maharashtra, India | |||
| Kentergarden Parftmary Industries Private Limited | ₹1.02 Lakh (FY 2019) | Paschim Mednapur, West Bengal, India | ||||
| Dr Lee & Morris Pharma Private Limitedthis company | ₹1.02 Lakh (FY 2025) | -₹310 | -0.3% | -3.0% | Mumbai, Maharashtra, India | |
| Pushpdhara Dealer Private Limited | ₹1.02 Lakh (FY 2018) | 6.0% | Howrah, West Bengal, India | |||
| Morin Auto Private Limited | ₹1.02 Lakh (FY 2024) | Gurgaon, Haryana, India | ||||
| Braahmanah Trading Private Limited | ₹1.02 Lakh (FY 2019) | 750.0% | Ghaziabad, Uttar Pradesh, India | |||
| RTM Hotels Private Limited | ₹1.02 Lakh (FY 2025) | -3.0% | Delhi, India | |||
| Trinav Digital Private Limited | ₹1.02 Lakh (FY 2024) | -68.0% | Ghasipura, Odisha, India | |||
| Shree Kalkitrends Private Limited | ₹1.02 Lakh (FY 2025) | 61.0% | Kota, Rajasthan, India | |||
| Organspharma Labs Private Limited | ₹1.02 Lakh (FY 2022) | Agra, Uttar Pradesh, India |
To see the full peer comparison of Dr Lee & Morris Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dr Lee & Morris Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr Lee & Morris Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dr Lee & Morris Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD5161L1ZE | Maharashtra | Active | 04 Jun 2018 |
To see the full GST registrations and return filing status of Dr Lee & Morris Pharma Private Limited, buy the company report.
Recent activity
Dr Lee & Morris Pharma Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Shradha Rani Sahu was appointed as Additional Director on 27 Feb 2020.
Frequently asked questions
Dr Lee & Morris Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in other services, within the business services industry. It was incorporated on 17 January 2018 (8+ years old) and is registered under CIN U74999MH2018PTC304334.
Dr Lee & Morris Pharma has 2 current directors:
- Manish Kumar Sahu - Additional Director
- Shradha Rani Sahu - Additional Director
The latest financial statements of Dr Lee & Morris Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Dr Lee & Morris Pharma is 27AAGCD5161L1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dr Lee & Morris Pharma is U74999MH2018PTC304334. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr Lee & Morris Pharma was incorporated on 17 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dr Lee & Morris Pharma by revenue are Pharmexia Labs Private Limited, Kasturi Steel Alloys Private Limited, Kentergarden Parftmary Industries Private Limited, Pushpdhara Dealer Private Limited, Morin Auto Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Shradha Rani Sahu was appointed as Additional Director on 27 Feb 2020. Khan Gufran ceased to be Director on 26 Feb 2020. Lallu Gupta Ram ceased to be Director on 16 Mar 2018. Dr Lee & Morris Pharma has 4 board changes on record in total.
The registered office of Dr Lee & Morris Pharma is at H.10 Vaibhav Nagar Borla W.T Patil Marg Chembur, Mumbai, Maharashtra, India – 400071.
Dr Lee & Morris Pharma operates in the business services industry, in the other services segment.
Dr Lee & Morris Pharma can be reached at its registered office: H.10 Vaibhav Nagar Borla W.T Patil Marg Chembur, Mumbai, Maharashtra, India – 400071.